Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48


Histogram Analysis of en face Scattering Coefficient Map Predicts Malignancy in Human Ovarian Tissue.

Zeng Y, Nandy S, Rao B, Li S, Hagemann AR, Kuroki LK, McCourt C, Mutch DG, Powell MA, Hagemann IS, Zhu Q.

J Biophotonics. 2019 Jul 14:e201900115. doi: 10.1002/jbio.201900115. [Epub ahead of print]


Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?

Liang B, Lange SS, Massad LS, Dick R, Mills KA, Hagemann AR, McCourt CK, Thaker PH, Fuh KC, Mutch DG, Powell MA, Kuroki LM.

Gynecol Oncol Rep. 2019 Apr 24;28:136-140. doi: 10.1016/j.gore.2019.04.007. eCollection 2019 May.


Wound Complication Rates After Vulvar Excisions for Premalignant Lesions.

Mullen MM, Merfeld EC, Palisoul ML, Massad LS, Woolfolk C, Powell MA, Mutch DG, Thaker PH, Hagemann AR, Kuroki LM.

Obstet Gynecol. 2019 Apr;133(4):658-665. doi: 10.1097/AOG.0000000000003185.


Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?

Cripe JC, Buchanan TR Jr, Wan L, Hagemann AR, McCourt CK, Massad LS, Fuh KC, Mutch DG, Powell MA, Thaker PH, Kuroki LM.

Gynecol Oncol Rep. 2019 Jan 26;28:1-5. doi: 10.1016/j.gore.2019.01.005. eCollection 2019 May.


Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.

Cripe JC, Buchanan TR Jr, Kuroki LM, Wan L, Mills KA, Massad L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Matsuo K, Thaker PH.

Gynecol Oncol. 2019 Apr;153(1):123-126. doi: 10.1016/j.ygyno.2019.01.009. Epub 2019 Jan 14.


Obesity counseling in obstetrics and gynecology: provider perceptions and barriers.

Huepenbecker SP, Wan L, Leon A, Rosen D, Hoff J, Kuroki LM, Fuh KC, Powell MA, Mutch DG, Colditz GA, Hagemann AR.

Gynecol Oncol Rep. 2018 Dec 10;27:31-34. doi: 10.1016/j.gore.2018.12.001. eCollection 2019 Feb. French.


Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.

Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Mol Cancer Ther. 2019 Feb;18(2):389-398. doi: 10.1158/1535-7163.MCT-18-0537. Epub 2018 Nov 26.


SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.

Mills KA, Roach ST, Quinn JM, Guo L, Beck HM, Lomonosova E, Ilivicky AR, Starks CM, Lawrence JA, Hagemann AR, McCourt C, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Gynecol Oncol. 2018 Nov;151(2):337-344. doi: 10.1016/j.ygyno.2018.08.008. Epub 2018 Sep 3.


Gynecologic Oncologists' Perceptions of Palliative Care and Associated Barriers: A Survey of the Society of Gynecologic Oncology.

Cripe JC, Mills KA, Kuroki LK, Wan L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Thaker PH.

Gynecol Obstet Invest. 2019;84(1):50-55. doi: 10.1159/000491089. Epub 2018 Aug 10. Review.


Defining and mitigating the challenges of an older and obese population in minimally invasive gynecologic cancer surgery.

Hagemann AR, McCourt CK, Varaday SS, Moore KN.

Gynecol Oncol. 2018 Mar;148(3):601-608. doi: 10.1016/j.ygyno.2017.12.020. Epub 2018 Jan 10. Review.


Cervical clear cell adenocarcinoma with an exceptionally low proliferation index: Report of a case.

Dandulakis MG, Mattis AJ, Hagemann AR, Hagemann IS.

Gynecol Oncol Rep. 2018 Jan 2;23:16-19. doi: 10.1016/j.gore.2017.12.006. eCollection 2018 Feb.


Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.

Binder PS, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS.

Gynecol Oncol. 2017 Nov;147(2):309-314. doi: 10.1016/j.ygyno.2017.08.031. Epub 2017 Sep 13.


Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.

Palisoul ML, Quinn JM, Schepers E, Hagemann IS, Guo L, Reger K, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Mol Cancer Ther. 2017 Dec;16(12):2881-2891. doi: 10.1158/1535-7163.MCT-17-0587. Epub 2017 Sep 13.


The effect of a multidisciplinary palliative care initiative on end of life care in gynecologic oncology patients.

Mullen MM, Divine LM, Porcelli BP, Wilkinson-Ryan I, Dans MC, Powell MA, Mutch DG, Hagemann AR, Thaker PH.

Gynecol Oncol. 2017 Nov;147(2):460-464. doi: 10.1016/j.ygyno.2017.08.002. Epub 2017 Aug 4.


Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial.

Kuroki LM, Mullen MM, Massad LS, Wu N, Liu J, Mutch DG, Powell MA, Hagemann AR, Thaker PH, McCourt CK, Novetsky AP.

Obstet Gynecol. 2017 Jul;130(1):91-99. doi: 10.1097/AOG.0000000000002061.


Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.

Ioffe YJ, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH, Schwarz JK, Grigsby PW.

Gynecol Obstet Invest. 2018;83(1):83-89. doi: 10.1159/000458706. Epub 2017 Apr 8.


A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Jandial DA, Brady WE, Howell SB, Lankes HA, Schilder RJ, Beumer JH, Christner SM, Strychor S, Powell MA, Hagemann AR, Moore KN, Walker JL, DiSilvestro PA, Duska LR, Fracasso PM, Dizon DS.

Gynecol Oncol. 2017 May;145(2):236-242. doi: 10.1016/j.ygyno.2017.03.013. Epub 2017 Mar 22.


AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.

Divine LM, Nguyen MR, Meller E, Desai RA, Arif B, Rankin EB, Bligard KH, Meyerson C, Hagemann IS, Massad M, Thaker PH, Hagemann AR, McCourt CK, Powell MA, Mutch DG, Fuh KC.

Oncotarget. 2016 Nov 22;7(47):77291-77305. doi: 10.18632/oncotarget.12637.


Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Divine LM, Kizer NT, Hagemann AR, Pittman ME, Chen L, Powell MA, Mutch DG, Rader JS, Thaker PH.

Gynecol Oncol. 2016 Jul;142(1):76-82. doi: 10.1016/j.ygyno.2016.04.030. Epub 2016 May 8.


Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics.

Aranake-Chrisinger J, Huettner PC, Hagemann AR, Pfeifer JD.

Hum Pathol. 2016 Jun;52:92-100. doi: 10.1016/j.humpath.2016.01.005. Epub 2016 Feb 4.


Obesity Education Strategies for Cancer Prevention in Women's Health.

Liu L, Segura A, Hagemann AR.

Curr Obstet Gynecol Rep. 2015 Dec 1;4(4):249-258. Epub 2015 Oct 13.


Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery.

Corr BR, Winter AM, Sammel MD, Chu CS, Gage BF, Hagemann AR.

Gynecol Oncol. 2015 Sep;138(3):501-6. doi: 10.1016/j.ygyno.2015.07.017. Epub 2015 Jul 14.


Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer.

Kuroki LM, Benn TE, Dukes JL, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Massad LS, Zighelboim I.

Gynecol Oncol Rep. 2015 Apr;12:41-44.


Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.

Frolova AI, Babb SA, Zantow E, Hagemann AR, Powell MA, Thaker PH, Gao F, Mutch DG.

Gynecol Oncol. 2015 Apr;137(1):7-13. doi: 10.1016/j.ygyno.2015.01.535. Epub 2015 Jan 21.


Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.

Wilkinson-Ryan I, Frolova AI, Liu J, Stewart Massad L, Thaker PH, Powell MA, Mutch DG, Hagemann AR.

Int J Gynecol Cancer. 2015 Jan;25(1):63-8. doi: 10.1097/IGC.0000000000000321.


Correlation of pelvic magnetic resonance imaging diagnosis with pathology for indeterminate adnexal masses.

Haggerty AF, Hagemann AR, Chu C, Siegelman ES, Rubin SC.

Int J Gynecol Cancer. 2014 Sep;24(7):1215-21. doi: 10.1097/IGC.0000000000000203.


A case of ovarian cancer metastases causing a symptomatic paraesophageal hernia.

Wolfe M, Wilkinson-Ryan I, Hagemann AR, Thaker PH.

Am J Obstet Gynecol. 2014 Nov;211(5):568.e1-2. doi: 10.1016/j.ajog.2014.07.040. Epub 2014 Jul 25. No abstract available.


A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients.

Novetsky AP, Zighelboim I, Guntupalli SR, Ioffe YJ, Kizer NT, Hagemann AR, Powell MA, Thaker PH, Mutch DG, Massad LS.

Gynecol Oncol. 2014 Aug;134(2):233-7. doi: 10.1016/j.ygyno.2014.06.012. Epub 2014 Jun 18.


Etiology and workup of fevers in gynecologic oncology patients.

McCartney SA, Sabo MC, Massad LS, Hagemann AR, Mutch DG, Powell MA, Thaker PH, Novetsky AP.

Int J Gynecol Cancer. 2014 Jun;24(5):950-5. doi: 10.1097/IGC.0000000000000129.


Postradiation damage to the pelvic girdle in cervical cancer patients: is intensity-modulated radiation therapy safer than conventional radiation?

Ioffe YJ, Hillen TJ, Zhou G, Schwarz JK, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH.

Int J Gynecol Cancer. 2014 May;24(4):806-12. doi: 10.1097/IGC.0000000000000117.


Disclosing a diagnosis of cancer: considerations specific to gynecologic oncology patients.

Kuroki LM, Zhao Q, Jeffe DB, Powell MA, Hagemann AR, Thaker PH, Massad LS, Mutch DG, Zighelboim I.

Obstet Gynecol. 2013 Nov;122(5):1033-9. doi: 10.1097/AOG.0b013e3182a9bf42.


Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer.

Hagemann AR, Novetsky AP, Zighelboim I, Gao F, Massad LS, Thaker PH, Powell MA, Mutch DG, Wright JD.

Gynecol Oncol. 2013 Dec;131(3):535-40. doi: 10.1016/j.ygyno.2013.09.032. Epub 2013 Oct 4.


A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.

Chiang CL, Kandalaft LE, Tanyi J, Hagemann AR, Motz GT, Svoronos N, Montone K, Mantia-Smaldone GM, Smith L, Nisenbaum HL, Levine BL, Kalos M, Czerniecki BJ, Torigian DA, Powell DJ Jr, Mick R, Coukos G.

Clin Cancer Res. 2013 Sep 1;19(17):4801-15. doi: 10.1158/1078-0432.CCR-13-1185. Epub 2013 Jul 9.


Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.

Novetsky AP, Smith K, Babb SA, Jeffe DB, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Massad LS, Zighelboim I.

Int J Gynecol Cancer. 2013 Jul;23(6):1016-21. doi: 10.1097/IGC.0b013e3182994365.


Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?

Garg G, Massad LS, Pourabolghasem S, Zhou G, Powell MA, Thaker PH, Hagemann AR, Wilkinson-Ryan I, Mutch DG.

Gynecol Oncol. 2013 Jun;129(3):538-43. doi: 10.1016/j.ygyno.2013.03.004. Epub 2013 Mar 13.


Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins.

Ioffe YJ, Erickson BK, Foster KE, Mutch DG, Powell MA, Thaker PH, Hagemann AR, Conner MG, Huh WK, Massad LS.

Gynecol Oncol. 2013 Jun;129(3):528-32. doi: 10.1016/j.ygyno.2013.02.033. Epub 2013 Mar 6.


Discussion: 'Comparison of cervical cancer screening strategies,' by Cox et al.

Hagemann AR, Wilkinson-Ryan I, Kuroki LM, Squires K.

Am J Obstet Gynecol. 2013 Mar;208(3):e1-4. doi: 10.1016/j.ajog.2013.01.036. Epub 2013 Jan 24.


The utility and management of vaginal cytology after treatment for endometrial cancer.

Novetsky AP, Kuroki LM, Massad LS, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Zighelboim I.

Obstet Gynecol. 2013 Jan;121(1):129-35. doi: http://10.1097/AOG.0b013e31827499a9.


The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer.

Garg G, Gao F, Wright JD, Hagemann AR, Zighelboim I, Mutch DG, Powell MA.

Int J Gynecol Cancer. 2013 Jan;23(1):90-7. doi: 10.1097/IGC.0b013e318275afd2.


Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.

Garg G, Gao F, Wright JD, Hagemann AR, Mutch DG, Powell MA.

Gynecol Oncol. 2013 Jan;128(1):77-82. doi: 10.1016/j.ygyno.2012.09.026. Epub 2012 Sep 29.


Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.

Chiang CL, Hagemann AR, Leskowitz R, Mick R, Garrabrant T, Czerniecki BJ, Kandalaft LE, Powell DJ Jr, Coukos G.

PLoS One. 2011;6(12):e28732. doi: 10.1371/journal.pone.0028732. Epub 2011 Dec 14.


Risk of occult malignancy in morcellated hysterectomy: a case series.

Hagemann IS, Hagemann AR, LiVolsi VA, Montone KT, Chu CS.

Int J Gynecol Pathol. 2011 Sep;30(5):476-83. doi: 10.1097/PGP.0b013e3182107ecf.


Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.

Hagemann AR, Hagemann IS, Cadungog M, Hwang WT, Patel P, Lal P, Hammond R, Gimotty PA, Chu CS, Rubin SC, Birrer MJ, Powell DJ Jr, Feldman MD, Coukos G.

Cancer Biol Ther. 2011 Aug 15;12(4):367-77. Epub 2011 Aug 15.


Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.

Hagemann AR, Cadungog M, Hagemann IS, Hammond R, Adams SF, Chu CS, Rubin SC, Zhang L, Addya K, Birrer MJ, Gimotty PA, Coukos G.

Cancer Biol Ther. 2011 Aug 15;12(4):357-66. Epub 2011 Aug 15.


Clinical predictors of bevacizumab-associated gastrointestinal perforation.

Tanyi JL, McCann G, Hagemann AR, Coukos G, Rubin SC, Liao JB, Chu CS.

Gynecol Oncol. 2011 Mar;120(3):464-9. doi: 10.1016/j.ygyno.2010.11.009. Epub 2010 Dec 17.


Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer.

Hagemann AR, Zighelboim I, Odibo AO, Rader JS, Mutch DG, Powell MA.

Breast J. 2011 Jan-Feb;17(1):103-5. doi: 10.1111/j.1524-4741.2010.01017.x. Epub 2010 Dec 14. No abstract available.


Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity.

Liao JB, Jean S, Wilkinson-Ryan I, Ford AE, Tanyi JL, Hagemann AR, Lin LL, McGrath CM, Rubin SC.

Gynecol Oncol. 2011 Jan;120(1):108-12. doi: 10.1016/j.ygyno.2010.09.005.


A prospective, randomized, double-blinded study of assisted hatching in women younger than 38 years undergoing in vitro fertilization.

Hagemann AR, Lanzendorf SE, Jungheim ES, Chang AS, Ratts VS, Odem RR.

Fertil Steril. 2010 Feb;93(2):586-91. doi: 10.1016/j.fertnstert.2009.01.116. Epub 2009 Mar 6.


Supplemental Content

Loading ...
Support Center